EUVIMEDEUVIMED entdecken
Kommentar

Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.

Jingzhe Xiang, Hao Zhang

Thyroid® · 2024-03 · 34 (3) · 399-400

DOI: 10.1089/thy.2023.0605 ↗

Kurz gefasst

Kommentar in der Zeitschrift Thyroid®, online erschienen am 16.01.2024. Verfasst von Jingzhe Xiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Thyroxine, Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineThyroid NeoplasmsCarcinoma, PapillaryHumansWatchful WaitingRiskThyroidectomy

Substanzen

Thyroxine

Autor:innen und Institutionen

  • Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.

Zitieren

APA

Xiang, J., & Zhang, H. (2024). Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al. Thyroid®, 34(3), 399-400. https://doi.org/10.1089/thy.2023.0605

Vancouver

Xiang J, Zhang H. Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al. Thyroid®. 2024;34(3):399-400. doi:10.1089/thy.2023.0605

BibTeX
@article{Xiang2024,
  author = {Xiang, Jingzhe and Zhang, Hao},
  title = {Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al},
  journal = {Thyroid®},
  year = {2024},
  volume = {34},
  number = {3},
  pages = {399--400},
  doi = {10.1089/thy.2023.0605}
}
Kostenlos starten →